It was previously shown that the NEP inhibition by specific inhibitors resulted in a decrease in osteosarcoma cell growth, which indicated neutral endopeptidase as a promising target of anticancer therapies in this case [23]. The gene discussed is MME; the disease is osteosarcoma.